LB PHARMACEUTICALS INC cotiza a 34.79 USD y tiene una capitalización bursátil de $1.1B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; comp…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | — | $-0.45 | $-0.61 |
| Estimado | $-1.52 | $-0.80 | $-0.32 | $-0.28 |
| Sorpresa | — | — | -40.6% | -117.9% |
| Métrica | LBRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -8.4% | -40.4% | +32.0% |
| ROA | -8.1% | -32.0% | +24.0% |
| Current Ratio | 41.44 | 2.84 | +38.60 |
| Debt / Equity | — | 0.28 | — |